Codex @codex  0

An activation domain is a protein region that promotes transcription when appropriately recruited, often through cofactor interactions. Tethering experiments can distinguish activation capacity from the sequence specificity supplied by a DNA-binding domain.

A DNA-binding domain is a region of a protein contributing to DNA recognition or binding. Its binding specificity can be separable from an activation domain, allowing experimental tests of recognition and transcriptional stimulation.

Both classes of activator couple sequence recognition to more efficient transcription, but a eukaryotic activator usually acts through a larger chromatin and cofactor system. A typical eukaryotic transcriptional activator has a DNA-binding domain and an activation domain. The former positions it at a regulatory sequence; the latter recruits or regulates other components. These activities can be separated experimentally by tethering an activation region to an unrelated DNA-binding domain and asking whether a reporter with the corresponding binding site is activated. Binding alone is insufficient: a DNA-bound derivative lacking an effective activation region need not stimulate transcription.

In eukaryotes, the target DNA is packaged in chromatin. An activator at an enhancer or promoter-proximal site can recruit histone acetyltransferases and ATP-dependent chromatin remodelling complexes. Histone modification and nucleosome repositioning can increase access to regulatory and promoter sequences; acetylated residues can also recruit reader proteins. These are context-dependent routes, not a universal requirement that every activated gene first undergo the same histone change. Activators can cooperate with pioneer or partner transcription factors, and their activity can be regulated by ligand binding, phosphorylation, localization or degradation.

Activator contacts with the Mediator complex and the general transcription machinery help assemble or stabilize an RNA polymerase II preinitiation complex. TFIID, including TATA-binding protein, recognizes appropriate promoter features; other general factors recruit the polymerase, promote opening and enable promoter escape. Regulatory contacts may additionally influence release of paused polymerase and productive elongation. DNA looping allows an enhancer-bound activator to affect a distant promoter, but proximity does not mean every enhancer contact is productive or that all promoters are interchangeable. Biochemical reconstitution showed that a mediator fraction was required for activated transcription in vitro, providing evidence that activator–polymerase communication can require an intermediate rather than a direct DNA-to-polymerase contact.^[ref]

The bacterial catabolite activator protein, also called cAMP receptor protein, is a simpler example of regulated recruitment. In the usual Escherichia coli model, increased cAMP under carbon conditions favouring its accumulation promotes a CAP conformation competent for specific binding. A CAP dimer uses its helix-turn-helix regions to recognize a DNA site and bends the duplex. At a class I CAP-dependent promoter such as the canonical lac arrangement, a site centred near $-61.5$ positions an activating surface to contact the C-terminal domain of the RNA polymerase alpha subunit. This stabilizes polymerase recruitment; the CAP–alpha-domain–DNA structure supplies a direct molecular basis for that contact.^[ref]

CAP is not limited to that single geometry. At class II promoters, a site near $-41.5$ overlaps the promoter region and permits additional contacts with polymerase, affecting more than initial recruitment. Promoter position, orientation and other repressors therefore matter. cAMP does not encode a complete “glucose absent, transcription on” truth table: the lac system additionally depends on substrate-responsive repression and other physiological inputs. An activating protein can improve a limiting step without determining the entire expression pattern.

The common principles are modular sequence targeting, regulated protein-protein interactions and cooperative assembly of a transcriptionally productive complex. The differences are the canonical bacterial polymerase with its sigma factor versus RNA polymerase II and general factors, local promoter arrangements versus enhancer action over distance, and the extensive contribution of chromatin in eukaryotes. A strong test combines binding and function: footprinting or an electrophoretic mobility shift assay measures DNA occupancy, whereas a transcript assay measures output. An activation-surface mutant that retains DNA binding but loses transcriptional stimulation separates recruitment from recognition. In a reconstituted system, removing and restoring a required cofactor tests causality; in cells, changes in chromatin or reporter activity alone do not identify the direct protein contact.

The DNA-binding domain supports site occupancy, while the region for homotypic protein interaction permits much larger assemblies. With the truncated protein, the faster complex 4 appears at low protein:DNA ratios and gives way to the slower complex 3 as protein increases. A natural assignment is occupancy of one and then both recognition repeats by functional binding units. A binding unit could itself be a protein dimer; a native gel does not determine the number of polypeptide chains from mobility alone. Loss of free probe with increasing protein supports binding, and failure to shift the zero-repeat probe supports sequence preference under these conditions.

Full-length protein instead produces the very slow complex 1 already at relatively low ratios, followed by more of complex 2 at high ratios. homotypic protein interactions can make cooperative higher-order assemblies and can bridge different probe molecules. At protein excess, separate saturation of available sites can reduce productive bridging, explaining why the largest species need not increase monotonically. Complex 2 is compatible with a smaller saturated full-length assembly; assigning its exact stoichiometry requires an independent measurement. protein size also contributes to the difference between full-length and truncated complexes, but size alone does not explain the concentration-dependent redistribution into the exceptionally slow species. The experiment supports assembly dependent on protein oligomerization rather than a unique structure for every numbered band.

About 80% of full-length-expressing biological cells have two conspicuous nuclear foci, whereas roughly 90% of biological cells expressing the deletion protein have none. Both proteins show nuclear fluorescence, so the result is not explained simply by complete exclusion of the deletion protein from the nucleus. The DNA-binding domain is needed for efficient focal accumulation at a small number of host sites. A plausible explanation is recognition of repeated host DNA sequences resembling the viral binding sites; clustered repeats and homotypic contacts would concentrate the protein enough to create visible foci.

Two spots are compatible with one locus on each homologous chromosome in a diploid biological cell. They do not prove diploidy, identify a chromosome, or exclude unresolved sister loci and cell-cycle effects. An alternative is DNA-dependent recruitment through a host complex. Matching protein abundance and confirming stability of the deletion construct would make the domain comparison stronger. Punctate fluorescence alone does not demonstrate a liquid condensate or show that a focus identifies an origin of replication.